C83.25 Mixed small and large cell (diffuse) non-Hodgkin's lymphoma, lymph nodes of inguinal region and lower limb

Name of the Condition

• Mixed small and large cell (diffuse) non-Hodgkin's lymphoma, lymph nodes of inguinal region and lower limb
• Also known as ICD-10 code C83.25

Summary

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of both small and large lymphoid cells in a diffuse pattern. It typically involves abnormal growth of B-cells or T-cells in the lymph nodes of the inguinal region and lower limb, without forming follicular structures. This condition is part of the broader category of non-follicular lymphomas and may present with variable clinical behavior depending on the specific cell composition and distribution.

Causes

The exact cause of mixed small and large cell (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in lymphoid cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in the inguinal region or lower limb.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI), and biopsy of the affected lymph nodes. Pathological analysis confirms the presence of mixed small and large cell lymphoma, and additional tests (e.g., flow cytometry, immunohistochemistry) may be used to characterize the cell type and rule out other conditions. Staging may include further imaging or bone marrow biopsy to assess disease extent.

Treatment Options

Treatment depends on the stage, grade, and patient factors. Options may include chemotherapy, immunotherapy, targeted therapy, or radiation therapy. In some cases, a combination of these approaches is used. Clinical trials or specialized protocols may be considered for advanced or refractory disease.

Prognosis and Follow-Up

Prognosis varies based on the specific subtype, stage, and patient response to treatment. Regular follow-up with imaging and clinical assessments is typically recommended to monitor for recurrence or progression. Long-term surveillance may be necessary, especially if the disease is aggressive or if treatment-related complications arise.

Complications

Potential complications include disease progression, treatment-related side effects (e.g., infection, organ toxicity), and secondary malignancies. Lymphoma may also spread to other organs or tissues, leading to additional symptoms or functional impairment.

Lifestyle & Prevention

While no specific preventive measures exist, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive radiation exposure) may support overall health. Prompt evaluation of persistent lymph node swelling or systemic symptoms is advised.

When to Seek Professional Help

Seek medical attention for persistent or worsening lymph node swelling, unexplained weight loss, fever, night sweats, or fatigue. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

When coding C83.25, ensure documentation specifies the involvement of lymph nodes in the inguinal region and lower limb. Verify that the diagnosis aligns with the mixed small and large cell (diffuse) non-Hodgkin's lymphoma subtype and that site-specific details are clearly documented to support accurate code assignment.